Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silence Therapeutics Plc - American Depository Share
(NQ:
SLN
)
6.100
-1.030 (-14.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silence Therapeutics Plc - American Depository Share
< Previous
1
2
3
4
5
6
Next >
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
November 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
September 26, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in September Investor Conferences
September 06, 2023
From
Silence Therapeutics plc
Via
Business Wire
Where Silence Therapeutics Stands With Analysts
↗
August 17, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Silence Therapeutics
↗
June 26, 2023
Via
Benzinga
The Latest Analyst Ratings for Silence Therapeutics
↗
May 11, 2023
Via
Benzinga
Silence Therapeutics Reports Second Quarter 2023 Results
August 16, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
July 11, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For August 10, 2023
↗
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Silence Therapeutics Reports First Quarter 2023 Results
May 16, 2023
From
Silence Therapeutics plc
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
↗
May 08, 2023
Via
Benzinga
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
May 04, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Completes Enrollment in Phase 2 Study of Zerlasiran (SLN360) in Subjects with Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
May 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Investor Conference
April 25, 2023
From
Silence Therapeutics plc
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 17, 2023
Via
Benzinga
Silence Therapeutics Announces Publication in Blood Demonstrating Role for Iron Regulation in Polycythemia Vera
April 04, 2023
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
↗
April 25, 2023
Tuesday's session saw 286 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 29, 2023
On Wednesday, 81 companies hit new 52-week lows.
Via
Benzinga
Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
March 29, 2023
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
↗
April 21, 2023
During Friday's session, 149 stocks hit new 52-week lows.
Via
Benzinga
Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
March 28, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Buyback siRNA Complement Assets
March 28, 2023
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For March 15, 2023
↗
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
March 15, 2023
Via
Benzinga
Silence Therapeutics Reports Fourth Quarter and Full Year 2022 Results
March 15, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Report Fourth Quarter and Full Year 2022 Results on March 15, 2023
March 02, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at SVB Securities Global Biopharma Conference
February 08, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officer
February 06, 2023
From
Silence Therapeutics plc
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
